Related Experiment Video
Updated: May 4, 2026

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
Published on: August 11, 2015
How we treat Richter syndrome
Sameer A Parikh1, Neil E Kay, Tait D Shanafelt
1Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.
Richter syndrome (RS) is a transformation of chronic lymphocytic leukemia (CLL) into aggressive lymphoma. Management involves biopsy, PET scans, and chemotherapy, with stem cell transplant considered for eligible patients.
Area of Science:
- Hematology
- Oncology
- Pathology
Background:
- Richter syndrome (RS) is the transformation of chronic lymphocytic leukemia (CLL) into aggressive lymphoma, occurring in 2-10% of CLL patients.
- Risk factors include genetic, clinical, and therapeutic elements of CLL.
- Recent research highlights genetic mutations like CDKN2A loss and TP53 disruption in CLL transformation.
More Related Videos
07:20Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy
Published on: August 9, 2024
11:17Protocol for Repetitive Transcranial Magnetic Stimulation with Symptom Provocation to Treat Obsessive-compulsive Disorder
Published on: November 25, 2025
Related Concept Videos
Rheumatic Heart Disease III: Medical Management
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Cardiomyopathy IV: Restrictive Cardiomyopathy
Rheumatic Heart Disease IV: Nursing Management
Myocarditis III: Medical Management
Mitral Regurgitation III: Medical Management